1.How to correctly understand the effect of metformin in the treatment of polycystic ovary syndrome
Chinese Journal of Endocrinology and Metabolism 2012;28(8):609-610
Metformin has been used in treating the patients with polycystic ovary syndrome (PCOS) for more than a decade.This article discusses its effect on the improvement of ovulation and hyperandrogenemia.
2.More attention should be paid to metabolic disorders in polycystic ovary syndrome
Chinese Journal of Endocrinology and Metabolism 2010;26(5):349-350
The prevalence of polycystic ovary syndrome (PCOS) in fertile aged women is about 6%. Many studies show that insulin resistance in PCOS is closely associated with metabolic disorders, which may even potentially increases the risk for cardiovascular diseases. Therefore, metabolic disorders in PCOS should be controlled more actively.
3.Viewing at use of glucagon-like peptide-1 in treatment of type 2 diabetes based on the secretion characters of incretins
Chinese Journal of Endocrinology and Metabolism 2011;27(4):后插1-后插4
Recently, in the field of pathogenesis and treatment of type 2 diabetes, incretin is a major breakthrough. Based on the knowledge about physiological mechanism, pathological characters, and clinical application, this review article summarized the mechanism of nutrients ( glucose, fat, and protein) mediated incretin secretion, the impairment of incretin secretion and action in type 2 diabetes and glucagon-like peptide-1 's use in type 2 diabetic patients.
4.Investigation of the role of health education in hypertension treatment
Chinese Medical Ethics 1994;0(06):-
The author has done a clinical trial of health education project in 53 cases of mild or moderate hypertension patients aged 35-75 years.He investigates and compares the differences of patients' awareness of the disease,compliance of doctor's advice,control of blood pressure before and after the implementation of health education,then discusses the role of health education in hypertension treatment and puts forward several medical ethical issues existed in the treatment of hypertension.
5.Progress in the mechanisms of glucocorticoid resistance in ectopic ACTH syndrome
Chinese Journal of Endocrinology and Metabolism 2008;24(6):686-688
High level of eetopie serum ACTH can not be suppressed by endogenous or exogenous glucocorticoid, this is the cardinal characteristic of ectopic ACTH syndrome (EAS), that is to say there exists glucocorticoid resistance in EAS. However, the mechanism of glucocorticoid resistance remains unclear. Identifying the mechanism can help us to diagnose and treat the disease. This review focuses on the mechanism of glucocorticoid resistance from several aspects, including the pre-glucocorticoid receptor (GR), GR and post-GR.
6.Public health information websites in China and USA and their enlightenments
Chinese Journal of Medical Library and Information Science 2016;25(4):17-20,40
The CHealth and MedlinePlus?were comparatively analyzed in aspects of their authority, resource de-velopment, information organization and usage, and website design with suggestions proposed for the construction of public health information websites in China.
7.Determination of Gastrodin in Choudongning Capsule by HPLC
China Pharmacy 2007;0(27):-
OBJECTIVE:To establish an HPLC method for the determination of gastrodin in Choudongning capsule. METHODS:The sample was determined on Elite C18 column(250 mm?4.6 mm,5 ?m);the mobile phase consisted of methanol -water(3∶97) at a flow rate of 1.0 mL?min-1;the detection wavelength was set at 221 nm. RESULTS:The linear range of gastrodin was from 0.051 ?g to 0.357 ?g(r=0.999 9) and its average recovery was 98.99%(RSD=1.91%,n=6).CONCL-USION:The method is convenient,accurate and reproducible,and it is applicable for the quality control of Choudongning capsule.
8.Determination of Cinobufagin and Resibufogenin in Yigankang Capsule by HPLC
China Pharmacy 2007;0(30):-
OBJECTIVE:To establish an HPLC method for the determination of the contents of cinobufagin and resibufogenin in Yigankang capsule.METHODS:The samples were separated on Spherigel ODS C18(150 mm?4.6 mm,5 ?m)chromatographic column with 0.5% KH2PO4-acetonitrile(50∶50,pH was adjusted to 3.2 by phosphoric acid)used as a mobile phase at a flow rate of 1.0 mL?min-1.The detection wavelength was set at 296 nm and the column temperature was kept at 40 ℃.RESULTS:The linear ranges of cinobufagin and resibufogenin were 0.22~1.09 ?g(r=0.999 8)and 0.26~1.30 ?g(r=0.999 9),respectively,and the average recoveries of cinobufagin and resibufogenin were 99.4%(RSD=1.9%,n=9)and 98.7%(RSD=1.4%,n=9),respectively.CONCLUSION:This method is proved to be sensitive,simple,accurate and specific,and it is applicable for the quality control of Yigankang capsule.
9.Three-dimensional finite element analysis for internal maxillary distraction with fixation between cleft palate
Chinese Journal of Medical Aesthetics and Cosmetology 2012;(5):327-330
Objective To investigate the biomechanical changes of internal maxillary distraction with fixation between cleft palate.Methods Three-dimensional FEM models of LeFort Ⅰ osteotomy and soft tissue in CLP maxillary complex were established.Two different conditions were simulated:one was the cleft palate connected by a titanium plate,and the other was the cleft retained.Internal midface distraction which applied in clinic were simulated.Fixation points of the distraction devices on the LeFort Ⅰ osteotomy complex were advanced by 10 mm in the direction of frontage.Biomechanical changes for different conditions were investigated by means of finite element analyses.Results LeFort Ⅰ osteotomy of maxillary complex area in CLP was advanced.Constrictions occurred in alveolar crest and palate,when the cleft was retained.Constriction of alveolar crest and palate was not obvious,when the cleft palate was connected by a titanium plate.There were no differences between sagittal and vertical displacement to internal distraction in LeFort Ⅰ osteotomy.Clockwise rotation occurred in vertical direction.Conclusions Internal maxillary distraction with fixation between cleft palate could avoid constriction of alveolar crest and palate.It provides the options and reference to the surgical plans.
10.Progression of genetic study in idiopathic hypogonadotropic hypogonadism
Chinese Journal of Endocrinology and Metabolism 2012;28(3):244-248
Idiopathic hypogonadotropic hypogonadism(IHH) is a complex oligogenic disease.About 60% of patients are associated with anosmia or hyposmia,also known as Kallmann syndrome. Based on genetic and molecular biological research,about more than ten IHH responsible genes have been discovered.